All,
I saw in a posting to the PARKINSN list that Amgen was looking for
volunteers for Phase II and III testing of the drug GPI-1046. For
those of you who aren't following the latest news on this drug, here
is a link:
http://www.parkinson.org/amgen.htm
(Sounds like a magic pill, doesn't it?)
Anway, I called the number for Amgen this morning, forgetting that
they are on the left coast. An answering service picked up the early
call. I was told to call back at 7am (Pacific time) and ask for a
"pipeline specialist." I have no clue what a pipeline specialist is,
but I did as instructed. You know, I still don't know what a
pipeline specialist is, but it seems to have been quite amusing to
the nice lady who answered and took some basic information about me.
She transferred me over to the neurology specialist. Unfortunately
there I found that they were all ready full up with volunteers. Here
are the details that I gleaned from the conversation:
o Phase I testing is still underway in Europe.
o Phase II testing already has enough volunteers.
o Phase III testing will probably begin in 8 to 10 months conditional
on Phase I & II results. They really are not making plans or taking
names yet. That will be done only when Phase II is complete and
analyzed.
o I was told to call back in 7 or 8 months. (I've instructed my
computer to remind me.)
o I was reminded that if I did join there would only be a 50% chance
of getting the drug (double blind test).
You can be sure that I will be watching the news to this drug with a
worm on my tongue ("baited breath").
Bill
(wannabe Guinea Pig)
--
Bill Innanen <mailto: [log in to unmask]>
<http://Bill.Innanen.com> & <http://mni.ms>
